Sweatman - Antipsychotics and Drug Syndromes Flashcards
What are the names of the typical antipsychotics?
- PHENOTHIAZINES: Chlorpromazine, Fluphenazine, Perphenazine
- THIOXANTHINES: Thiothixene
- BUTYROPHENONES (di/phenylbutylpiperidines): Haloperidol
- NOTE: classified based on structure
What are the names of the atypical antipsychotics?
- Clozapine
- Risperidone
- Olanzapine
- Quetiapine
- Ziprasidone
- Aripiprazole
- Paliperidone
- NEW: Iliperidone, Asenapine, Lurasidone
How are all drugs that treat psychosis similar?
- All dopamine (D2) antagonists
- NOTE: AC inhibited by D2 and activated by D1 GCPR’s
What are some drugs that can exacerbate psychosis? How?
- Agents associated w/INC dopamine activity
- Amphetamines, methylphenidate (Ritalin), cocaine
- NOTE: these drugs may cause psychosis, or make it more severe
What determines the potency of the antipsychotics?
- Clinical potency correlates with in vitro INH of D2 receptor binding
- NOTE: blocking D2 receptors relieves (+) symptoms
What other receptors (besides D2) do antipsychotics block? What effects does this binding cause?
- To varying degrees (MASH):
- Muscarinic - confusion, memory impairment, and protection against EPS
- Alpha-1-adrenergic - autonomic side effects like orthostatic hypotension and tachycardia
- Serotonin 5-HT2 - relieve (-) symptoms
- Histamine (H1) - sedation
What is the key difference between the MOA of the typical and atypical antipsychotics? Why does this matter?
- Relative to typical, 1st-gen, atypical (2nd-gen) show:
- Lower affinity for D2 receptors (DEC RISK OF EPS)
- Higher affinity for 5-HT2 receptors
- Typical may produce EPS compared to atypical, which are unlikely to
How do the side effect profiles vary between potent and weak antipsychotics?
- POTENT: INC risk of EPS
- WEAK: additional sedative, hypotensive, and autonomic effects
What are the common features of the typical AP’s?
- Dopamine (D2) blockers
- Produce EPS
- Elevate PRL levels
- Equally effective, but differ in potency and side effects
- Largely effective for (+) symptoms, e.g., delusions, hallucinations, disorganization of thought and behavior
What are the common features of the atypical AP’s?
- Share D2 and 5HT2A antagonism in common
- Addition of 5HT2A blockade may:
- Reduce EPS
- Improve efficacy for (-) symptoms, e.g., withdrawal, flat affect, paucity of thought, avolition (poor initiation of goal-directed behavior)
How do the structures of the typical AP’s affect their potency and side effect profiles?
- PHENOTHIAZINES/THIOXANTHENES:
- Chlorpromazine (ALIPHATIC side chain) and Thiothixene (PIPERIDINE ring side chain): low potency -> lower incidence of EPS, but may be associated w/INC anti-muscarinic effects
- Fluphenazine, Perphenazine (PIPERAZINE group in side chain) - potent, INC risk of EPS, weak anticholinergic effects
- BUTYROPHENONES:
- Haloperidol - high potency
Describe the pharma profile of Clozapine, Olanzapine, and Quetiapine.
- ATYPICALS
- Low potency
- Anti-serotonin effects that may be useful in treating (-) symptoms
Describe the pharma profile of Risperidone. What other 2 agents have similar profiles?
- 5HT2/D2 antagonist
- Limited EPS at low doses, but acts more like a typical antipsychotic at high doses (INC risk of EPS at high doses)
- Only approved agent for use in CHILDREN/TEENS
- Paliperidone (active metabolite of Risperidone) and Ziprasidone (limited EPS) have similar profiles
What is the MOA of Aripiprazole?
- D2 partial agonist that reduces actions of full agonist
- 5-HT2A antagonist and 5-HT1A partial agonist
- Lower incidence of side effects
What is the MOA of Asenapine?
- D1, D2, 5-HT1, 5-HT2, alpha-adrenergic, and histamine receptor antagonist
- Low affinity for muscarinic receptors
What is neuroleptic syndrome?
- Series of behavioral effects produced by the AP’s (similar effects and therapeutic responses):
- Suppression of spontaneous movements and complex behaviors
- Reduced initiative and interest in envo
- DEC manifestations of emotion or affect
- Psychotic symptoms (hallucinations, delusions, disorganized and incoherent thinking) appear to disappear over a period of days
- NOTE: do not confuse with NMS, which is life-threatening, and involves muscle rigidity, fever, autonomic instability, and cognitive changes such as delirium; associated with elevated plasma creatine phosphokinase
How do AP’s affect the limbic system?
- Thought to be the site of AP effects responsible for reduction of psychosis, esp. the (+) symptoms
- Dopamine system adapts to long-term therapy: INC synthesis, release, and neuronal activity to overcome receptor blockade
- Anticholinergics do NOT block therapeutic effect bc they do not affect DA turnover in limbic system
How do AP’s affect the basal ganglia?
- Suggested that DEC dopamine activity associated with EPS and neuro effects
- AP’s consistently INC dopamine metabolism
- Initially INC dopamine metabolism, synthesis, and firing rate; diminishes with time due to adaptation to tx
- Antipsychotic effects not thought to occur here
- Unlike in limbic system, anticholinergics block AP-induced INC in DA turnover in basal ganglia, and consequently block symptoms of EPS -> this results from restoration of balance between cholinergic and dopamine systems in this region
What are the EPS of the AP’s?
- Acute dystonia
- Akathesia
- Parkinsonian syndrome
- Neuroleptic malignant syndrome (NMS)
- Perioral tremor (delayed)
- Tardive dyskinesia (delayed)
- NOTE: prominent during tx with high potency typical AP’s, but less likely to occur w/low-potency AP’s and atypicals
What are the symptoms and tx for acute dystonia?
- SYMPTOMS: muscle spasms, facial grimacing, torticollis (stiff neck), oculogyeric crisis
- Spasms to face and neck that usually occur w/in first 5 DAYS
- TX: anticholinergic antiparkinsonian agents, i.e., BENZTROPINE
What are the symptoms and tx for akathesia?
- SYMPTOMS: strong subjective feelings of distress or discomfort, often related to legs -> compelling need to be in constant motion
- “Ants in the pants”
- TX: DEC dose, add antiparkinsonian agent, anti-anxiety agent or Propranolol
- Occurs w/in 5-60 DAYS
What are the symptoms and tx of parkinsonian syndrome?
- SYMPTOMS: akinesia (loss/impairment of voluntary mvmt), mask facies, DEC arm mvmt, rigidity, tremor
- Develops gradually during 1ST MONTH
- TX: anticholinergic antiparkinsonian agents, Amantadine
- NOTE: may be indistinguishable from idiopathic PD, but use of L-dopa or Bromocriptine will induce agitation, and enhance psychosis -> NOT recommended
What are the features of neuroleptic malignant syndrome (NMS)? Tx?
- Rare; high mortality (10%)
- SYMPTOMS: fever, severe parkinsonism with catatonia, fluctuations in coarse tremor intensity, autonomic instability (labile pulse, BP, hyperthermia), elevated creatine kinase, myoglobinemia (does not always occur)
- Usually appears within WEEKS OF ONSET OF THERAPY
- TX: immediate cessation of antipsychotic, supportive care, Dantrolene (fever) or Bromocriptine (competes for dopa receptors) may help
- Specific tx’s are generally unsatisfactory
What are the features of perioral tremor? Tx?
- Rare
- Might appear w/in MONTHS TO YEARS of therapy
- SYMPTOMS: rabbit syndrome
- TX: anticholinergic agents, STOP antipsychotic